All Stories

  1. Frontiers of Molecular Biology of Cancer

    Article • International Journal of Molecular Sciences, December 2023, MDPI AG

    Professor Stergios Boussios

  2. Immune checkpoint inhibitors in patients with cancers of unknown primary

    Article • European Journal of Cancer, December 2023, Elsevier

    Professor Stergios Boussios

  3. Frontiers of Ovarian Carcinosarcoma

    Article • Current Treatment Options in Oncology, November 2023, Springer Science + Business Media

    Professor Stergios Boussios

  4. COVID-19 Associated Mucormycosis and Cytomegalovirus Infection – A Case Report

    Article • November 2023, MDPI AG

    Professor Stergios Boussios

  5. Renal Cell Cancer – Insights in Drug Resistance Mechanisms

    Article • Anticancer Research, November 2023, International Institute of Anticancer Research

    Professor Stergios Boussios

  6. The integration of palliative care with oncology: the path ahead

    Article • Annals of Palliative Medicine, November 2023, AME Publishing Company

    Professor Stergios Boussios

  7. Cardiac Toxicities in Oncology: Elucidating the Dark Box in the Era of Precision Medicine

    Article • Current Issues in Molecular Biology, October 2023, MDPI AG

    Professor Stergios Boussios

  8. Exosomes in the Diagnosis and Treatment of Renal Cell Cancer

    Article • International Journal of Molecular Sciences, September 2023, MDPI AG

    Professor Stergios Boussios

  9. Prognostic Factors in Patients with Metastatic Spinal Cord Compression Secondary to Lung Cancer—A Retrospective UK Single-Centre Study

    Article • Cancers, September 2023, MDPI AG

    Professor Stergios Boussios

  10. Gestational Renal Cell Cancer – An Update

    Article • Anticancer Research, August 2023, International Institute of Anticancer Research

    Professor Stergios Boussios

  11. Hallmarks of the Tumour Microenvironment of Gliomas and Its Interaction with Emerging Immunotherapy Modalities

    Article • International Journal of Molecular Sciences, August 2023, MDPI AG

    Professor Stergios Boussios

  12. Re: Pain and Health-related Quality of Life with Olaparib Versus Physician’s Choice of Next-generation Hormonal Drug in Patients with Metastatic Castration-resistant Prostate Cancer with Homologous Recombination Repair Gene Alterations (PROfound): An O...

    Article • European Urology, August 2023, Elsevier

    Professor Stergios Boussios

  13. Prognostic Factors in Patients with Metastatic Spinal Cord Compression Secondary to Lung Cancer – a Retrospective UK Single-Center Study

    Article • July 2023, MDPI AG

    Professor Stergios Boussios

  14. Emerging Hallmarks of the Tumour Microenvironment of Gliomas and the Interplay with Immunotherapy

    Article • July 2023, MDPI AG

    Professor Stergios Boussios

  15. Advances in Ovarian Cancer Treatment Beyond PARP Inhibitors

    Article • Current Cancer Drug Targets, July 2023, Bentham Science Publishers

    Professor Stergios Boussios

  16. Advances in adoptive T-cell therapy for metastatic melanoma

    Article • Current Research in Translational Medicine, July 2023, Elsevier

    Professor Stergios Boussios

  17. Clinical Challenges in the Management of Malignant Ovarian Germ Cell Tumours

    Article • International Journal of Environmental Research and Public Health, June 2023, MDPI AG

    Professor Stergios Boussios

  18. Impact of COVID-19 on cancer services and patients’ outcomes: a retrospective single-center study

    Article • Annals of Translational Medicine, June 2023, AME Publishing Company

    Professor Stergios Boussios

  19. State-of-the-Art Molecular Oncology in UK

    Article • International Journal of Molecular Sciences, May 2023, MDPI AG

    Professor Stergios Boussios

  20. Posterior Reversible Encephalopathy Syndrome after Pazopanib Therapy

    Article • Diseases, May 2023, MDPI AG

    Professor Stergios Boussios

  21. Clinico-Pathological Factors Determining Recurrence of Phyllodes Tumors of the Breast: The 25-Year Experience at a Tertiary Cancer Centre

    Article • Journal of Personalized Medicine, May 2023, MDPI AG

    Professor Stergios Boussios

  22. Abiraterone acetate plus prednisolone with or without enzalutamide for patients with metastatic prostate cancer starting androgen deprivation therapy: final results from two randomised phase 3 trials of the STAMPEDE platform protocol

    Article • The Lancet Oncology, May 2023, Elsevier

    Professor Stergios Boussios

  23. Prostate cancer—what about oligometastatic disease and stereotactic ablative radiotherapy?—a narrative review

    Article • Annals of Palliative Medicine, May 2023, AME Publishing Company

    Professor Stergios Boussios

  24. From Biology to Diagnosis and Treatment: The Ariadne’s Thread in Cancer of Unknown Primary

    Article • International Journal of Molecular Sciences, March 2023, MDPI AG

    Professor Stergios Boussios

  25. Constrictive Pericarditis–A Cloak Camouflaging Lymphoma

    Article • Hematology Reports, March 2023, MDPI AG

    Professor Stergios Boussios

  26. Temporary treatment cessation versus continuation of first-line tyrosine kinase inhibitor in patients with advanced clear cell renal cell carcinoma (STAR): an open-label, non-inferiority, randomised, controlled, phase 2/3 trial

    Article • The Lancet Oncology, March 2023, Elsevier

    Professor Stergios Boussios

  27. Aberrations of DNA Repair Pathways in Prostate Cancer—The State of the Art

    Article • International Journal of Molecular Sciences, February 2023, MDPI AG

    Professor Stergios Boussios

  28. HPV and Cervical Cancer: A Review of Epidemiology and Screening Uptake in the UK

    Article • Pathogens, February 2023, MDPI AG

    Professor Stergios Boussios

  29. Predictive biomarkers for immune checkpoint inhibitor response in urothelial cancer

    Article • Therapeutic Advances in Medical Oncology, January 2023, SAGE Publications

    Professor Stergios Boussios

  30. Efficacy and Safety of COVID-19 Vaccines—An Update

    Article • Diseases, November 2022, MDPI AG

    Professor Stergios Boussios

  31. A Primary Mediastinal Monophasic Spindle-Cell Synovial Sarcoma with Superior Venacaval Obstruction

    Article • Diseases, November 2022, MDPI AG

    Professor Stergios Boussios

  32. Hereditary Ovarian Cancer: Towards a Cost-Effective Prevention Strategy

    Article • International Journal of Environmental Research and Public Health, September 2022, MDPI AG

    Professor Stergios Boussios

  33. Surgery for T4 Colorectal Cancer in Older Patients: Determinants of Outcomes

    Article • Journal of Personalized Medicine, September 2022, MDPI AG

    Professor Stergios Boussios

  34. Chromosomal instability in cancers of unknown primary

    Article • European Journal of Cancer, September 2022, Elsevier

    Professor Stergios Boussios

  35. BRCA Mutations in Ovarian and Prostate Cancer: Bench to Bedside

    Article • Cancers, August 2022, MDPI AG

    Professor Stergios Boussios

  36. Recent Insights into PARP and Immuno-Checkpoint Inhibitors in Epithelial Ovarian Cancer

    Article • International Journal of Environmental Research and Public Health, July 2022, MDPI AG

    Professor Stergios Boussios

  37. COVID-19, Mucormycosis and Cancer: The Triple Threat—Hypothesis or Reality?

    Article • Journal of Personalized Medicine, July 2022, MDPI AG

    Professor Stergios Boussios

  38. Epithelial Ovarian Cancer: Providing Evidence of Predisposition Genes

    Article • International Journal of Environmental Research and Public Health, July 2022, MDPI AG

    Professor Stergios Boussios

  39. Microsatellite instability testing in colorectal patients with Lynch syndrome: lessons learned from a case report and how to avoid such pitfalls

    Article • Personalized Medicine, July 2022, Future Medicine

    Professor Stergios Boussios

  40. Sarcoma of unknown primary: myth or reality?

    Article • Journal of the Egyptian National Cancer Institute, June 2022, Springer Science + Business Media

    Professor Stergios Boussios

  41. Systematic review of the CUP trials characteristics and perspectives for next-generation studies

    Article • Cancer Treatment Reviews, June 2022, Elsevier

    Professor Stergios Boussios

  42. Applications of Proteomics in Ovarian Cancer: Dawn of a New Era

    Article • Proteomes, May 2022, MDPI AG

    Professor Stergios Boussios

  43. Androgen Receptor Gene Pathway Upregulation and Radiation Resistance in Oligometastatic Prostate Cancer

    Article • International Journal of Molecular Sciences, April 2022, MDPI AG

    Professor Stergios Boussios

  44. Epilepsy and Diagnostic Dilemmas: The Role of Language and Speech-Related Seizures

    Article • Journal of Personalized Medicine, April 2022, MDPI AG

    Professor Stergios Boussios

  45. Metastatic Anorectal Melanoma Presenting as Seizures: An Infrequent Culprit

    Article • Diseases, April 2022, MDPI AG

    Professor Stergios Boussios

  46. Case of cerebral venous thrombosis on a patient with background of nephrotic syndrome

    Article • BMJ Case Reports, March 2022, BMJ

    Professor Stergios Boussios

  47. Systematic review of fetal and placental metastases among pregnant patients with cancer

    Article • Cancer Treatment Reviews, March 2022, Elsevier

    Professor Stergios Boussios

  48. Non-Epithelial Ovarian Cancers: How Much Do We Really Know?

    Article • International Journal of Environmental Research and Public Health, January 2022, MDPI AG

    Professor Stergios Boussios

  49. Abiraterone acetate and prednisolone with or without enzalutamide for high-risk non-metastatic prostate cancer: a meta-analysis of primary results from two randomised controlled phase 3 trials of the STAMPEDE platform protocol

    Article • The Lancet, January 2022, Elsevier

    Professor Stergios Boussios

  50. The outcome of patients with serous papillary peritoneal cancer, fallopian tube cancer, and epithelial ovarian cancer by treatment eras: 27 years data from the SEER registry

    Article • Cancer Epidemiology, December 2021, Elsevier

    Professor Stergios Boussios

  51. BRCA Mutations in Prostate Cancer: Assessment, Implications and Treatment Considerations

    Article • International Journal of Molecular Sciences, November 2021, MDPI AG

    Professor Stergios Boussios

  52. The Experience of a Single NHS England Trust on the Impact of the COVID-19 Pandemic on Junior and Middle-Grade Doctors: What Is Next?

    Article • International Journal of Environmental Research and Public Health, October 2021, MDPI AG

    Professor Stergios Boussios

  53. Angiogenesis and Anti-Angiogenic Treatment in Prostate Cancer: Mechanisms of Action and Molecular Targets

    Article • International Journal of Molecular Sciences, September 2021, MDPI AG

    Professor Stergios Boussios

  54. Genetic Aberrations of DNA Repair Pathways in Prostate Cancer: Translation to the Clinic

    Article • International Journal of Molecular Sciences, September 2021, MDPI AG

    Professor Stergios Boussios

  55. Unraveling the Wide Spectrum of Melanoma Biomarkers

    Article • Diagnostics, July 2021, MDPI AG

    Professor Stergios Boussios

  56. Genomic correlates of response and resistance to immune checkpoint inhibitors in carcinomas of unknown primary

    Article • European Journal of Clinical Investigation, May 2021, Wiley

    Professor Stergios Boussios

  57. Aberrations of DNA repair pathways in prostate cancer: a cornerstone of precision oncology

    Article • Expert Opinion on Therapeutic Targets, May 2021, Taylor & Francis

    Professor Stergios Boussios

  58. Cancer-Associated Thrombosis: A New Light on an Old Story

    Article • Diseases, May 2021, MDPI AG

    Professor Stergios Boussios

  59. Comparative genomic characterization of melanoma of known and unknown primary

    Article • Clinical & Translational Oncology, May 2021, Springer Science + Business Media

    Professor Stergios Boussios

  60. Immuno-oncology: a narrative review of gastrointestinal and hepatic toxicities

    Article • Annals of Translational Medicine, March 2021, AME Publishing Company

    Professor Stergios Boussios

  61. Management of Metastatic Spinal Cord Compression in Secondary Care: A Practice Reflection from Medway Maritime Hospital, Kent, UK

    Article • Journal of Personalized Medicine, February 2021, MDPI AG

    Professor Stergios Boussios

  62. Melanoma of unknown primary: New perspectives for an old story

    Article • Critical Reviews in Oncology/Hematology, February 2021, Elsevier

    Professor Stergios Boussios

  63. Current and future immunotherapy approaches in ovarian cancer

    Article • Annals of Translational Medicine, December 2020, AME Publishing Company

    Professor Stergios Boussios

  64. Development of new poly(ADP-ribose) polymerase (PARP) inhibitors in ovarian cancer: Quo Vadis?

    Article • Annals of Translational Medicine, December 2020, AME Publishing Company

    Professor Stergios Boussios

  65. Endometriosis-associated ovarian carcinomas: insights into pathogenesis, diagnostics, and therapeutic targets—a narrative review

    Article • Annals of Translational Medicine, December 2020, AME Publishing Company

    Professor Stergios Boussios

  66. Metformin and ovarian cancer: the evidence

    Article • Annals of Translational Medicine, December 2020, AME Publishing Company

    Professor Stergios Boussios

  67. NOTCH signalling in ovarian cancer angiogenesis

    Article • Annals of Translational Medicine, December 2020, AME Publishing Company

    Professor Stergios Boussios

  68. Narrative review on serous primary peritoneal carcinoma of unknown primary site: four questions to be answered

    Article • Annals of Translational Medicine, December 2020, AME Publishing Company

    Professor Stergios Boussios

  69. Neoadjuvant treatment for newly diagnosed advanced ovarian cancer: where do we stand and where are we going?

    Article • Annals of Translational Medicine, December 2020, AME Publishing Company

    Professor Stergios Boussios

  70. Ovarian cancer: state of the art and perspectives of clinical research

    Article • Annals of Translational Medicine, December 2020, AME Publishing Company

    Professor Stergios Boussios

  71. Systemic anti-cancer treatment in malignant ovarian germ cell tumours (MOGCTs): current management and promising approaches

    Article • Annals of Translational Medicine, December 2020, AME Publishing Company

    Professor Stergios Boussios

  72. Upfront debulking surgery for high-grade serous ovarian carcinoma: current evidence

    Article • Annals of Translational Medicine, December 2020, AME Publishing Company

    Professor Stergios Boussios

  73. An Update on the Prognostic and Predictive Serum Biomarkers in Metastatic Prostate Cancer

    Article • Diagnostics, July 2020, MDPI AG

    Professor Stergios Boussios

  74. Wise Management of Ovarian Cancer: On the Cutting Edge

    Article • Journal of Personalized Medicine, May 2020, MDPI AG

    Professor Stergios Boussios

  75. Poly (ADP-Ribose) Polymerase Inhibitors: Talazoparib in Ovarian Cancer and Beyond

    Article • Drugs in R&D, March 2020, Springer Science + Business Media

    Professor Stergios Boussios

  76. New rising entities in cancer of unknown primary: Is there a real therapeutic benefit?

    Article • Critical Reviews in Oncology/Hematology, March 2020, Elsevier

    Professor Stergios Boussios

  77. Veliparib in ovarian cancer: a new synthetically lethal therapeutic approach

    Article • Investigational New Drugs, October 2019, Springer Science + Business Media

    Professor Stergios Boussios

  78. Combined Strategies with Poly (ADP-Ribose) Polymerase (PARP) Inhibitors for the Treatment of Ovarian Cancer: A Literature Review

    Article • Diagnostics, August 2019, MDPI AG

    Professor Stergios Boussios

  79. PARP Inhibitors in Ovarian Cancer: The Route to “Ithaca”

    Article • Diagnostics, May 2019, MDPI AG

    Professor Stergios Boussios

  80. The Developing Story of Predictive Biomarkers in Colorectal Cancer

    Article • Journal of Personalized Medicine, February 2019, MDPI AG

    Professor Stergios Boussios

  81. Ovarian carcinosarcoma: Current developments and future perspectives

    Article • Critical Reviews in Oncology/Hematology, February 2019, Elsevier

    Professor Stergios Boussios

  82. Management of Recurrent Uterine Cervical Cancer

    Article • January 2019, Springer Science + Business Media

    Professor Stergios Boussios

  83. Spinal Ewing Sarcoma Debuting with Cord Compression: Have We Discovered the Thread of Ariadne?

    Article • Anticancer Research, October 2018, International Institute of Anticancer Research

    Professor Stergios Boussios

  84. Metastatic Spinal Cord Compression: Unraveling the Diagnostic and Therapeutic Challenges

    Article • Anticancer Research, September 2018, International Institute of Anticancer Research

    Professor Stergios Boussios

  85. A review on pregnancy complicated by ovarian epithelial and non-epithelial malignant tumors: Diagnostic and therapeutic perspectives

    Article • Journal of Advanced Research, July 2018, Elsevier

    Professor Stergios Boussios

  86. Extranodal diffuse large B-cell lymphomas: A retrospective case series and review of the literature

    Article • Hematology Reports, April 2018, MDPI AG

    Professor Stergios Boussios

  87. Malignant peritoneal mesothelioma: clinical aspects, and therapeutic perspectives

    Article • Annals of Gastroenterology, January 2018, Hellenic Society of Gastroenterology

    Professor Stergios Boussios

  88. Ovarian sex-cord stromal tumours and small cell tumours: Pathological, genetic and management aspects

    Article • Critical Reviews in Oncology/Hematology, December 2017, Elsevier

    Professor Stergios Boussios

  89. Precision medicine based on epigenomics: the paradigm of carcinoma of unknown primary

    Article • Nature Reviews Clinical Oncology, July 2017, Springer Science + Business Media

    Professor Stergios Boussios

  90. The Impact of Systemic Therapy Beyond First-line Treatment for Advanced Cervical Cancer

    Article • Clinical Oncology, March 2017, Elsevier

    Professor Stergios Boussios

  91. Dynamics of Neutrophils-to-Lymphocyte Ratio Predict Outcomes of PD-1/PD-L1 Blockade

    Article • BioMed Research International, January 2017, Hindawi Publishing Corporation

    Professor Stergios Boussios

  92. Primary Pulmonary Malignant Melanoma: Report of an Important Entity and Literature Review

    Article • Case Reports in Oncological Medicine, January 2017, Hindawi Publishing Corporation

    Professor Stergios Boussios, Chris Kyriakopoulos

  93. Current and future biomarkers in colorectal cancer

    Article • Annals of Gastroenterology, January 2017, Hellenic Society of Gastroenterology

    Professor Stergios Boussios

  94. Management of patients with recurrent/advanced cervical cancer beyond first line platinum regimens: Where do we stand? A literature review

    Article • Critical Reviews in Oncology/Hematology, December 2016, Elsevier

    Professor Stergios Boussios

  95. Non-epithelial Ovarian Cancer: Elucidating Uncommon Gynaecological Malignancies

    Article • Anticancer Research, October 2016, International Institute of Anticancer Research

    Professor Stergios Boussios

  96. Cancer specific risk in multiple sclerosis patients

    Article • Critical Reviews in Oncology/Hematology, February 2016, Elsevier

    Professor Stergios Boussios

  97. Pancreatic resection for renal cell carcinoma metastasis: An exceptionally rare coexistence

    Article • International Journal of Surgery Case Reports, January 2016, Elsevier

    Professor Stergios Boussios

  98. Bleomycin-Induced Flagellate Erythema in a Patient Diagnosed with Ovarian Yolk Sac Tumor

    Article • Case Reports in Oncological Medicine, January 2015, Hindawi Publishing Corporation

    Professor Stergios Boussios

  99. Neuroendocrine Cell Carcinoma of Unknown Primary Arising in Long Standing History of Multiple Sclerosis

    Article • Case Reports in Oncological Medicine, January 2015, Hindawi Publishing Corporation

    Professor Stergios Boussios

  100. Lung cancer in pregnancy: Report of nine cases from an international collaborative study

    Article • Lung Cancer, December 2013, Elsevier

    Professor Stergios Boussios

  101. Renal cell carcinoma in pregnancy: a rare coexistence

    Article • Clinical & Translational Oncology, September 2013, Springer Science + Business Media

    Professor Stergios Boussios